{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:50:59Z","timestamp":1767034259630},"reference-count":118,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.iac.2007.12.002","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T11:43:12Z","timestamp":1205408592000},"page":"119-136","source":"Crossref","is-referenced-by-count":21,"title":["Ocular Manifestations of Blistering Diseases"],"prefix":"10.1016","volume":"28","author":[{"given":"Samih","family":"Elchahal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R.","family":"Kavosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004397-199603610-00007","article-title":"Cicatricial pemphigoid: diagnosis and treatment","volume":"36","author":"Nguyen","year":"1996","journal-title":"Int Ophthalmol Clin"},{"issue":"3","key":"10.1016\/j.iac.2007.12.002_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00160769","article-title":"Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid","volume":"82","author":"Foster","year":"1992","journal-title":"Doc Ophthalmol"},{"issue":"6","key":"10.1016\/j.iac.2007.12.002_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0738-081X(00)00183-8","article-title":"Oral involvement in autoimmune blistering diseases","volume":"19","author":"Casiglia","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib4","doi-asserted-by":"crossref","first-page":"11579","DOI":"10.1073\/pnas.88.24.11579","article-title":"Association of DQw7 (DQB1\u22170301) with ocular cicatricial pemphigoid","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.iac.2007.12.002_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archopht.1995.01100020086034","article-title":"Ocular cicatricial pemphigoid: a case report of monozygotic twins discordant for the disease","volume":"113","author":"Bhol","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.iac.2007.12.002_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000246943","article-title":"High frequency of HLA-DQB1\u22170301 allele in patients with pure ocular cicatricial pemphigoid","volume":"189","author":"Chan","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.iac.2007.12.002_bib7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0733-8635(18)30246-8","article-title":"Cicatricial pemphigoid","volume":"11","author":"Mutasim","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.iac.2007.12.002_bib8","first-page":"891","article-title":"Cultured corneal epithelia for ocular surface disease","volume":"97","author":"Schwab","year":"1999","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"10.1016\/j.iac.2007.12.002_bib9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00003226-199811000-00001","article-title":"Conjunctival changes associated with glaucoma therapy: implications for the external disease consultant and the treatment of glaucoma","volume":"17","author":"Liesegang","year":"1998","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/eye.1998.66","article-title":"Drug-induced ocular cicatricial pemphigoid: a series of clinico-pathological reports","volume":"12","author":"Butt","year":"1998","journal-title":"Eye"},{"issue":"12","key":"10.1016\/j.iac.2007.12.002_bib11","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/archopht.1987.01060120058023","article-title":"Drug-induced pemphigoid: a spectrum of diseases","volume":"105","author":"Fiore","year":"1987","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.iac.2007.12.002_bib12","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.165.5.2824","article-title":"The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4","volume":"165","author":"Bhol","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.iac.2007.12.002_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/eye.1993.75","article-title":"Chronic progressive conjunctival cicatrisation","volume":"7","author":"Bernauer","year":"1993","journal-title":"Eye"},{"key":"10.1016\/j.iac.2007.12.002_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0161-6420(89)32922-8","article-title":"Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid: further evidence for a T cell-mediated disease","volume":"96","author":"Sacks","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.iac.2007.12.002_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/1523-1747.ep12323267","article-title":"Detection of eosinophil cationic protein in active ocular cicatricial pemphigoid. Abstracts for the 25th Annual Meeting of the European Society for Dermatological Research","volume":"105","author":"Schaller","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0161-6420(89)32790-4","article-title":"Mast cells in conjunctiva affected by cicatricial pemphigoid","volume":"96","author":"Hoang-Xuan","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.iac.2007.12.002_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0161-6420(93)31644-1","article-title":"The conjunctiva in acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis","volume":"100","author":"Bernauer","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.iac.2007.12.002_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2133.1988.tb01747.x","article-title":"The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid","volume":"118","author":"Kelly","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1988.tb01776.x","article-title":"Immunofluorescent studies in ocular cicatricial pemphigoid","volume":"118","author":"Leonard","year":"1988","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib20","first-page":"631","article-title":"Clinical and immunopathological correlation in cicatricial pemphigoid: a study of 36 cases. British Society for Investigative Dermatology Annual Meeting, Oxford, April 6\u20137, 1995","volume":"132","author":"Setterfield","year":"1995","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/j.iac.2007.12.002_bib21","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0161-6420(95)30896-2","article-title":"Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid","volume":"102","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.iac.2007.12.002_bib22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0190-9622(91)70152-R","article-title":"Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies","volume":"24","author":"Sarret","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/1523-1747.ep12876206","article-title":"Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis","volume":"94","author":"Bernard","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1523-1747.ep12259075","article-title":"Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid","volume":"82","author":"Fine","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2133.1982.tb04534.x","article-title":"Immunoelectron microscopic findings in cicatricial pemphigoid: their significance in relation to epidermolysis bullosa acquisita","volume":"106","author":"Nieboer","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib26","first-page":"805","article-title":"Direct immunoelectron microscopy on the conjunctiva in ocular cicatricial pemphigoid versus subepidermal autoimmune bullous dermatoses with ocular involvement: report of 10 cases. Abstracts for the 1996 Annual Meeting Society for Investigative Dermatology","volume":"106","author":"Prost","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1523-1747.ep12477198","article-title":"Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectron microscopy","volume":"97","author":"Bedane","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archderm.130.12.1521","article-title":"Antiepiligrin cicatricial pemphigoid: a subepithelial bullous disorder","volume":"130","author":"Domloge-Hultsch","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib29","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1172\/JCI116033","article-title":"Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domlodge-Hultsch","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.iac.2007.12.002_bib30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0190-9622(96)90086-9","article-title":"Antiepiligrin cicatricial pemphigoid: the first case report from Japan","volume":"34","author":"Hashimoto","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.iac.2007.12.002_bib31","first-page":"2283","article-title":"The role of antibody to human beta 4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid","volume":"40","author":"Chan","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02172711","article-title":"Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium","volume":"226","author":"Herbort","year":"1988","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1076\/0271-3683(200008)2121-VFT646","article-title":"Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study","volume":"21","author":"Letko","year":"2000","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.iac.2007.12.002_bib34","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1365-2133.2001.04543.x","article-title":"Cicatricial pemphigoid with circulating autoantibodies to beta 4 integrin, bullous pemphigoid 180, and bullous pemphigoid 230","volume":"145","author":"Leverkus","year":"2001","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(82)34791-0","article-title":"Immunosuppressive therapy for progressive ocular cicatricial pemphigoid","volume":"89","author":"Foster","year":"1982","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.iac.2007.12.002_bib36","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0161-6420(99)90496-7","article-title":"Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study","volume":"106","author":"Foster","year":"1999","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.iac.2007.12.002_bib37","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0161-6420(93)31487-9","article-title":"Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid. Implications for patient selection and surgical considerations","volume":"100","author":"Heiligenhaus","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.iac.2007.12.002_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0030-4220(86)90367-1","article-title":"Oral mucous membrane pemphigoid: a study of sixty-five patients","volume":"61","author":"Silverman","year":"1986","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"9","key":"10.1016\/j.iac.2007.12.002_bib39","first-page":"501","article-title":"Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid","volume":"77","author":"Celis Sanchez","year":"2002","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.iac.2007.12.002_bib40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.76.6.332","article-title":"Dapsone therapy for the acute inflammatory phase of ocular pemphigoid","volume":"76","author":"Fern","year":"1992","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.iac.2007.12.002_bib41","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","article-title":"Mycophenolate mofetil therapy for inflammatory eye disease","volume":"112","author":"Thorne","year":"2005","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.iac.2007.12.002_bib42","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/09546630600964999","article-title":"Treatment of refractory blistering autoimmune diseases with mycophenolic acid","volume":"17","author":"Marzano","year":"2006","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mjd.2001.114746","article-title":"Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent","volume":"45","author":"Megahed","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.iac.2007.12.002_bib44","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archderm.142.10.1268","article-title":"Successful treatment of mucous membrane pemphigoid with infliximab","volume":"142","author":"Heffernan","year":"2006","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib45","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(02)01932-2","article-title":"Treatment of ocular inflammatory disorders with daclizumab","volume":"110","author":"Papaliodis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.iac.2007.12.002_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0190-9622(82)70014-3","article-title":"Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone","volume":"6","author":"Rogers","year":"1982","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","article-title":"Rituximab in autoimmune bullous diseases: mixed responses and adverse effects","volume":"156","author":"Schmidt","year":"2007","journal-title":"Br J Dermatol"},{"issue":"17","key":"10.1016\/j.iac.2007.12.002_bib48","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.iac.2007.12.002_bib49","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1345\/aph.1K198","article-title":"Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid","volume":"41","author":"Gurcan","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.intimp.2005.11.018","article-title":"Use of intravenous immunoglobulin therapy in autoimmune blistering diseases","volume":"6","author":"Ahmed","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1016\/j.iac.2007.12.002_bib51","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2003.11.012","article-title":"Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up","volume":"111","author":"Sami","year":"2004","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00003226-200007000-00003","article-title":"Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease","volume":"19","author":"Schwab","year":"2000","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.iac.2007.12.002_bib53","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0161-6420(91)32209-7","article-title":"Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid","volume":"98","author":"Neumann","year":"1991","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9394(14)71962-2","article-title":"Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome","volume":"122","author":"Tsubota","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.iac.2007.12.002_bib55","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0161-6420(02)00994-6","article-title":"Limbal stem cell transplantation in chronic inflammatory eye disease","volume":"109","author":"Samson","year":"2002","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.iac.2007.12.002_bib56","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0161-6420(01)00694-7","article-title":"Cultivated corneal epithelial stem cell transplantation in ocular surface disorders","volume":"108","author":"Koizumi","year":"2001","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(00)00475-9","article-title":"Living related conjunctival limbal allograft for the treatment of stem cell deficiency","volume":"108","author":"Daya","year":"2001","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM200007133430202","article-title":"Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells","volume":"343","author":"Tsai","year":"2000","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.iac.2007.12.002_bib59","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199906033402201","article-title":"Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation","volume":"340","author":"Tsubota","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.iac.2007.12.002_bib60","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(88)33188-X","article-title":"Linear IgA disease. The ocular manifestations","volume":"95","author":"Aultbrinker","year":"1988","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.iac.2007.12.002_bib61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0738-081X(91)90030-O","article-title":"Linear IgA bullous dermatosis of adults","volume":"9","author":"Chorzelski","year":"1991","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.131.1.48","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2007.12.002_bib63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-2133.1999.03110.x","article-title":"Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression","volume":"141","author":"Collier","year":"1999","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2007.12.002_bib64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000246930","article-title":"Linear IgA disease: a heterogeneous disease","volume":"189","author":"Wojnarowska","year":"1994","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.iac.2007.12.002_bib65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0738-081X(91)90031-F","article-title":"Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood)","volume":"9","author":"Jablonska","year":"1991","journal-title":"Clin Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.iac.2007.12.002_bib66","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0190-9622(88)70236-4","article-title":"Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap","volume":"19","author":"Wojnarowska","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 2","key":"10.1016\/j.iac.2007.12.002_bib67","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0190-9622(00)90102-6","article-title":"Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency","volume":"42","author":"Klein","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199901000-00001","article-title":"Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature","volume":"78","author":"Nousari","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.iac.2007.12.002_bib69","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1346-8138.2005.tb00839.x","article-title":"Drug-induced linear IgA bullous dermatosis","volume":"32","author":"Onodera","year":"2005","journal-title":"J\u00a0Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2007.12.002_bib70","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1365-4362.1998.00544.x","article-title":"Captopril-triggered linear IgA bullous dermatosis","volume":"37","author":"Friedman","year":"1998","journal-title":"Int J Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.iac.2007.12.002_bib71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0190-9622(94)70015-X","article-title":"Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature","volume":"30","author":"Kuechle","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.iac.2007.12.002_bib72","first-page":"320","article-title":"Amiodarone-induced linear IgA disease","volume":"33","author":"Primka","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2 Pt 2","key":"10.1016\/j.iac.2007.12.002_bib73","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0190-9622(98)70582-1","article-title":"Phenytoin-induced linear IgA bullous disease","volume":"38","author":"Acostamadiedo","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2133.1988.tb03197.x","article-title":"A clinicopathological study of mucosal involvement in linear IgA disease","volume":"119","author":"Kelly","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib75","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/archderm.131.12.1438","article-title":"A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens","volume":"131","author":"Darling","year":"1995","journal-title":"Arch Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2007.12.002_bib76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000246933","article-title":"Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA","volume":"189","author":"Zone","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.iac.2007.12.002_bib77","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2230.1997.tb02627.x","article-title":"Linear IgA bullous dermatosis of childhood: treatment with dapsone and cotrimoxazole","volume":"22","author":"Pulimood","year":"1997","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1525-1470.1999.99015.x","article-title":"Treatment of linear IgA bullous dermatosis of childhood with colchicine","volume":"16","author":"Ang","year":"1999","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2007.12.002_bib79","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jaad.2006.06.029","article-title":"High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases","volume":"56","author":"Segura","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2007.12.002_bib80","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0161-6420(00)00245-1","article-title":"Linear IgA bullous disease limited to the eye: a diagnostic dilemma: response to intravenous immunoglobulin therapy","volume":"107","author":"Letko","year":"2000","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.iac.2007.12.002_bib81","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2133.2000.03395.x","article-title":"High-dose intravenous immune globulin is also effective in linear IgA disease","volume":"142","author":"Kroiss","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2007.12.002_bib82","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8561(05)70295-2","article-title":"Autoimmune subepithelial blistering diseases with ocular involvement","volume":"17","author":"Caux","year":"1997","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"5","key":"10.1016\/j.iac.2007.12.002_bib83","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1365-2133.1999.03176.x","article-title":"Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting","volume":"141","author":"Schattenkirchner","year":"1999","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib84","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clindermatol.2003.12.020","article-title":"Bullous systemic lupus erythematosus","volume":"22","author":"Vassileva","year":"2004","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2007.12.002_bib85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10227-001-0008-y","article-title":"Epidermolysis bullosa acquisita responsive to dapsone therapy","volume":"5","author":"Hughes","year":"2001","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"10","key":"10.1016\/j.iac.2007.12.002_bib86","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.4049\/jimmunol.178.10.6514","article-title":"The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita","volume":"178","author":"Mihai","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0923-1811(03)00092-6","article-title":"Immunofluorescence studies using skin sections of recessive dystrophic epidermolysis bullosa patients indicated that the antigen of anti-p200 pemphigoid is not a fragment of type VII collagen","volume":"32","author":"Liu","year":"2003","journal-title":"J Dermatol Sci"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib88","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2133.2006.07739.x","article-title":"Blindness due to the IgA variant of epidermolysis bullosa acquisita, and treatment with osteo-odonto-keratoprosthesis","volume":"156","author":"Cox","year":"2007","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib89","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1172\/JCI24855","article-title":"The pathophysiology of autoimmune blistering diseases","volume":"115","author":"Yancey","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.iac.2007.12.002_bib90","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2353\/ajpath.2007.061212","article-title":"The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita","volume":"170","author":"Chen","year":"2007","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.iac.2007.12.002_bib91","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1346-8138.2003.tb00376.x","article-title":"Epidermolysis bullosa acquisita in childhood","volume":"30","author":"Trigo-Guzman","year":"2003","journal-title":"J\u00a0Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib92","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00105-007-1284-2","article-title":"Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases","volume":"58","author":"Kasperkiewicz","year":"2007","journal-title":"Hautarzt"},{"key":"10.1016\/j.iac.2007.12.002_bib93","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/archopht.124.11.1615","article-title":"Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita","volume":"124","author":"Letko","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib94","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.2007.08048.x","article-title":"Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab","volume":"157","author":"Sadler","year":"2007","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2007.12.002_bib95","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1600-0625.2007.00564.x","article-title":"Experimental models of epidermolysis bullosa acquisita","volume":"16","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2007.12.002_bib96","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2133.2004.05933.x","article-title":"Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy","volume":"150","author":"Ishii","year":"2004","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib97","first-page":"20","article-title":"Autoimmune bullous diseases: diagnosis and management","volume":"18","author":"McCuin","year":"2006","journal-title":"Dermatol Nurs"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib98","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1902\/jop.2001.72.4.550","article-title":"Epidermolysis bullosa acquisita: clinical manifestations, microscopic findings, and surgical periodontal therapy. A case report","volume":"72","author":"Hakki","year":"2001","journal-title":"J\u00a0Periodontol"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0378-6323.19736","article-title":"Epidermolysis bullosa acquisita","volume":"72","author":"Das","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/000155501750208353","article-title":"Epidermolysis bullosa acquisita treated with basiliximab, an interleukin-2 receptor antibody","volume":"81","author":"Haufs","year":"2001","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.iac.2007.12.002_bib101","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0738-081X(00)00186-3","article-title":"Epidermolysis bullosa acquisita: update and review","volume":"19","author":"Hallel-Halevy","year":"2001","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib102","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D36222V7F3","article-title":"Epidermolysis bullosa acquisita","volume":"13","author":"Stein","year":"2007","journal-title":"Dermatol Online J"},{"issue":"10","key":"10.1016\/j.iac.2007.12.002_bib103","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archderm.138.10.1385","article-title":"IgM-mediated epidermolysis bullosa acquisita","volume":"138","author":"Suchniak","year":"2002","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2007.12.002_bib104","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004397-199703720-00006","article-title":"Ocular cicatricial pemphigoid and ocular manifestations of pemphigus vulgaris","volume":"37","author":"Smith","year":"1997","journal-title":"Int Ophthalmol Clin"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/00016350152509256","article-title":"Immunodiagnosis of pemphigus and mucous membrane pemphigoid","volume":"59","author":"Challacombe","year":"2001","journal-title":"Acta Odontol Scand"},{"issue":"7","key":"10.1016\/j.iac.2007.12.002_bib106","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1006\/cyto.1999.0642","article-title":"Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid","volume":"12","author":"Bhol","year":"2000","journal-title":"Cytokine"},{"issue":"13","key":"10.1016\/j.iac.2007.12.002_bib107","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2165\/00003495-200565130-00003","article-title":"Autoimmune bullous diseases: ocular manifestations and management","volume":"65","author":"Laforest","year":"2005","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib108","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2005.02.061","article-title":"Ocular pemphigus","volume":"53","author":"Daoud","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib109","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaad.2006.01.067","article-title":"Ocular involvement in pemphigus vulgaris","volume":"55","author":"Tenner","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2007.12.002_bib110","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-4632.2006.03044.x","article-title":"Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients","volume":"46","author":"Michailidou","year":"2007","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2007.12.002_bib111","first-page":"365","article-title":"Conjunctival blistering associated with pemphigus vulgaris: report of a case","volume":"80","author":"Bianciotto","year":"2005","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"8","key":"10.1016\/j.iac.2007.12.002_bib112","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archderm.139.8.1083","article-title":"Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment","volume":"139","author":"Hall","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1 Pt 1","key":"10.1016\/j.iac.2007.12.002_bib113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1542\/peds.112.1.183","article-title":"Pemphigus vulgaris: the eyes have it","volume":"112","author":"Merchant","year":"2003","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib114","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajo.2007.02.046","article-title":"Ocular involvement in pemphigus","volume":"144","author":"Palleschi","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.iac.2007.12.002_bib115","first-page":"230","article-title":"Bullous autoimmune diseases of the oral mucosa","volume":"100","author":"Vaillant","year":"1999","journal-title":"Rev Stomatol Chir Maxillofac"},{"issue":"1","key":"10.1016\/j.iac.2007.12.002_bib116","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-3083.1998.tb00924.x","article-title":"Use of recombinant pemphigus vulgaris antigen in development of ELISA and IB assays to detect pemphigus vulgaris autoantibodies","volume":"10","author":"Bhol","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.iac.2007.12.002_bib117","series-title":"Allergy and asthma: practical diagnosis and management","first-page":"21","article-title":"Allergic disease of the eye","author":"Kavosh","year":"2007"},{"issue":"5","key":"10.1016\/j.iac.2007.12.002_bib118","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2500\/aap2007.28.3034","article-title":"Letters to the editor","volume":"28","author":"Kavosh","year":"2007","journal-title":"Allergy Asthma Proc"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856107001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856107001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:38:29Z","timestamp":1708713509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856107001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0889856107001051"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2007.12.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}